General Information of the Compound
| Compound ID |
CP0042227
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-4-(2-Acetimidoylamino-ethylsulfanyl)-2-amino-butyric acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
(2S)-2-amino-4-[2-(1-aminoethylideneamino)ethylsulfanyl]butanoic acid
(S)-4-(2-Acetimidoylamino-ethylsulfanyl)-2-amino-butyric acid
0ZZF1V8G63
AKOS030526714
BDBM50086467
CHEMBL114551
CS-5419
DB12237
GTPL9849
GW-274150
GW-274150;GW 274150
GW274150
HY-12119
L-Homocysteine, S-(2-((1-iminoethyl)amino)ethyl)-
SCHEMBL120693
UNII-0ZZF1V8G63
ZINC2004483
[2-[(1-iminoethyl) amino]ethyl]-L-homocysteine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C8H17N3O2S
|
||||||||||||||||||
| Molecular Weight |
219.31
|
||||||||||||||||||
| Canonical SMILES |
CC(=N)NCCSCC[C@H](N)C(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C8H17N3O2S/c1-6(9)11-3-5-14-4-2-7(10)8(12)13/h7H,2-5,10H2,1H3,(H2,9,11)(H,12,13)/t7-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MOLOJNHYNHBPCW-ZETCQYMHSA-N
|
||||||||||||||||||
| CAS |
210354-22-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound